AI assistant
ELI LILLY & Co — Director's Dealing 2024
Jun 3, 2024
29745_dirs_2024-06-03_d9b46833-0ad1-46df-9b73-920b1a8ef5ff.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2024-06-03
Reporting Person: Norton Johna (EVP, Global Quality)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-06-03 | Common Stock | S | 7056 | $819.38 | Disposed | 25428 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 402 | Indirect |
| Common Stock | 1770 | Indirect |
| Common Stock | 128 | Indirect |
Footnotes
F1: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2024.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $818.80 to $819.59, inclusive. The reporting person undertakes to provide to Eli Lilly and Company, any security holder of Eli Lilly and Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.